Results 191 to 200 of about 74,781 (265)

Effects of Prior Local Therapy by Radical Prostatectomy or Radiotherapy on the Efficacy and Quality of Life of Patients Treated With Darolutamide in ARAMIS. [PDF]

Cancer Med
Saar M, Fizazi K, Shore ND, Smith M, Damber JE, Semenov A, Ribal MJ, Birtle A, Rigaud J, Wallis CJD, Grimm MO, Halabi S, Armstrong AJ, Mohamed AF, Adorjan P, Srinivasan S, Verholen F, Morgans AK, Siemens DR.   +18 more
europepmc   +1 more source

Understanding the Housing and Support Experience of People With Complex Disability in Australia: A Qualitative Analysis of Submissions to the Disability Royal Commission

Australian Journal of Social Issues, EarlyView.
ABSTRACT In 2019, the Australian government established the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability (‘Disability Royal Commission’, DRC) to investigate widespread mistreatment of people with disability. Nearly 10,000 people with disability, their families and supporters engaged with the DRC.
Kate D'Cruz, Fiona Carey, Libby Witts, Jessie Spence, Peter Mulherin, Megan Topping, Di Winkler, Jacinta Douglas   +7 more
wiley   +1 more source

One-year real-world outcomes after vericiguat initiation in heart failure: The ROVER-Japan cohort study. [PDF]

Int J Cardiol Heart Vasc
Takeichi M, Kohsaka S, Nochioka K, Ohlmeier C, Michel A, Holl K, Yamamoto H, Arita Y, Kim SW, Okami S.   +9 more
europepmc   +1 more source

The Cost of the National Disability Insurance Scheme: Australia's Print‐Media Discourse

Australian Journal of Social Issues, EarlyView.
ABSTRACT This paper examines the way that Australian newspapers have framed the cost of the National Disability Insurance Scheme (NDIS). Introduced in 2013, the NDIS represented a major change in Australia's disability support policy, moving for the first time to a nationwide universal insurance model.
Meera Chinnappa, Jennifer Smith‐Merry, Kuo‐yi Jade Chang   +2 more
wiley   +1 more source

Optimization of the Use of Generic Medications in Oncology: Improving Safety and Therapeutic Quality. [PDF]

J Clin Med
Gómez Abreo D, Alarcón Cano DF, Ayala F, Belalcázar Carvajal N, Berrouet Mejía MC, Beltrán O, Calderón-Ospina CA, Castro-Salguero H, Escobar Cárdenas DM, Lema-Medina M, Marín Zuluaga JI, Milla Bernabé P, Niño Velasco RE, Osorio Estévez R, Ortiz JM, Rojas-Melo LJ, Urrego M, Vargas C, Zuluaga AF.   +18 more
europepmc   +1 more source

Proteins and signalling pathways targeted by dapagliflozin and finerenone: Insights from DAPA-CKD and FIGARO-DKD. [PDF]

Diabetes Obes Metab
de la Rambelje MA, Voors AA, Greasley PJ, Berger M, Heerspink HJL.   +4 more
europepmc   +1 more source

Building Trust: Validating Artificial Intelligence (AI) and Machine Learning in Agricultural Applications. [PDF]

J Agric Food Chem
Riter LS, Bienstock RJ, O'Sullivan W.
europepmc   +1 more source

Regorafenib use in patients with unresectable hepatocellular carcinoma: analyses of subgroups of special interest in the observational REFINE study. [PDF]

ESMO Gastrointest Oncol
Kim YJ, Merle P, Finn RS, Klümpen HJ, Lim HY, Ikeda M, Granito A, Masi G, Gerolami R, Pinter M, Babajanyan S, Twumasi-Ankrah P, Ghadessi M, Ozgurdal K, Qin S.   +14 more
europepmc   +1 more source

The role of age in choosing high-efficacy treatment for multiple sclerosis: an Austrian MS Database study. [PDF]

J Neurol
Hegen H, Föttinger F, Walde J, Berek K, Martinez-Serrat M, Damulina A, Krajnc N, Ponleitner M, Di Pauli F, Enzinger C, Deisenhammer F, Berger T, Khalil M, Bsteh G, Austrian Multiple Sclerosis Database Study group.   +14 more
europepmc   +1 more source